Ovarian hyperstimulation associated with the sole use of leuprolide for ovarian suppression

J Yeh; R L Barbieri; V A Ravnikar

doi:10.1007/BF01132875

Ovarian hyperstimulation associated with the sole use of leuprolide for ovarian suppression

J In Vitro Fert Embryo Transf. 1989 Aug;6(4):261-3. doi: 10.1007/BF01132875.

Authors

J Yeh¹, R L Barbieri, V A Ravnikar

Affiliation

¹ Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115.

PMID: 2515236
DOI: 10.1007/BF01132875

Abstract

An IVF patient who was placed on leuprolide therapy prior to ovulation induction to improve ovarian response developed moderate ovarian hyperstimulation from the sole use of the GnRH agonist. Clinicians should be aware of this possible outcome.

Publication types

Case Reports

MeSH terms

Adult
Female
Gonadotropin-Releasing Hormone / adverse effects
Gonadotropin-Releasing Hormone / analogs & derivatives*
Humans
Leuprolide
Ovary / drug effects*
Ovulation Induction / methods*
Stimulation, Chemical

Substances

Gonadotropin-Releasing Hormone
Leuprolide